Editor
My Top Three Stocks Fueling the Space Age 🚀
I’ve always been fascinated by space… I grew up on Dune, 2001: A Space Odyssey, and (pre-Disney) Star Wars. The…
How Retail Investors Outplayed Wall Street in April
Retail investors crushed it in April 2025 — buying when hedge funds bailed and turning the chaos into gains. Here’s…
Consumers Are Scared, and That Means — Opportunity! The headlines have been impossible to miss: In 2025, consumer confidence has cratered. At his inauguration, President Trump promised…
Consumers Are Scared, and That Means — Opportunity! The headlines have been impossible to miss: In 2025, consumer confidence has…
The Auction Heard ‘Round Wall Street
Hey Folks, Jeff Bishop here, Around 1:00 ET yesterday, stock traders felt the ground shift beneath them. The markets had…
My Top 3 Stocks in Healthcare AI and Digital Health
AI is shaking up healthcare — cutting costs, speeding diagnoses, and transforming entire fields. From virtual visits to personalized treatment…
fmst
Sponsored by Sica Media and Disseminated on Behalf of Foremost Clean Energy* wednesday July 2, 2025 Foremost Clean Energy (Nasdaq:…
A Guide to Using X as a Day or Swing Trader
If you're trading FOMC events or chasing fast market moves, X (formerly Twitter) is your real-time edge — but only…
Why Palantir (PLTR) Has Been Soaring — And What Traders Can Learn From It
Why Palantir (PLTR) Has Been Soaring — And What Traders Can Learn From ItPalantir (PLTR)’s earnings release yesterday fell short…
Three Under-the-Radar Biotech Stocks Ready to Rally in 2025: A Wild Ride Awaits!
Welcome to the biotech jungle, where the vines are thick, the stakes are high, and the rewards can be downright…
BNTX: BioNTech – Buy or Sell This Biotech Trailblazer?
BioNTech (BNTX) is the biotech jungle’s speedy cheetah, sprinting at $95.50 (TipRanks) with a $35 billion market cap as of…
AMGN: Amgen – Buy or Sell This Biotech Bruiser?
Amgen (AMGN) is the biotech jungle’s hulking gorilla, stomping at $283.50 (TipRanks) with a $100 billion+ market cap as of…
REGN: Regeneron Pharmaceuticals – Buy or Sell This Biotech Brainiac?
Regeneron Pharmaceuticals (REGN) is the biotech jungle’s clever monkey, swinging at $730.30 (U.S. News) with a $103 billion market cap…
